Skip to main content
Amin Alousi, MD, Medicine/Pediatrics, Houston, TX, University of Texas M.D. Anderson Cancer Center

AminM.AlousiMD

Medicine/Pediatrics Houston, TX

M.D. Anderson Cancer Center

Dr. Alousi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Alousi's full profile

Already have an account?

Education & Training

  • Detroit Medical Center/Wayne State University
    Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 2002 - 2005
  • Detroit Medical Center/Wayne State University
    Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine/Pediatrics, 1997 - 2001
  • Wayne State University School of Medicine
    Wayne State University School of MedicineClass of 1997

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • TN State Medical License
    TN State Medical License 2023 - 2026
  • WA State Medical License
    WA State Medical License 2023 - 2026
  • TX State Medical License
    TX State Medical License 2006 - 2025
  • GA State Medical License
    GA State Medical License 2023 - 2025
  • AL State Medical License
    AL State Medical License 2023 - 2024
  • AZ State Medical License
    AZ State Medical License 2023 - 2024
  • American Board of Internal Medicine Hematology
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Pilot Study Using Post-Transplant Cyclophosphamide (PTCy), Tacrolimus and Mycophenolate GVHD Prophylaxis for Older Patients Receiving 10/10 HLA-Matched Unrelated Donor...  
    Uday R Popat, Amin Alousi, Issa F Khouri, Muzaffar Qazilbash, Richard E Champlin, Partow Kebriaei, Simrit Parmar, Chitra Hosing, Nature
  • Impact of a Novel Prognostic Model, Hematopoietic Cell Transplant-Composite Risk (HCT-CR), on Allogeneic Transplant Outcomes in Patients with Acute Myeloid Leukemia an...  
    Uday Popat, Chitra M Hosing, Issa Khouri, Richard Champlin, Simrit Parmar, Partow Kebriaei, Borje S Andersson, Qaiser Bashir, Amin Alousi, Nature
  • A Phase II/III Randomized, Multicenter Trial of Prednisone /Sirolimus vs Prednisone/Sirolimus/Calcineurin Inhibitor for Treatment of Chronic Graft-Versus-Host Disease:...  
    Amin M Alousi, Mukta Arora, Luciano J Costa, Aleksandr Lazaryan, Daniel J Weisdorf, Sunil Abhyankar, Eneida R Nemecek, Haematologica

Abstracts/Posters

  • Myeloablative Fractionated Busulfan Conditioning Regimen in Older Patients: Results of a Phase II Study
    Amin M. Alousi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Clinical Relevance of MYC/BCL2 and Cell of Origin in Patients with Relapsed Diffuse Large B-Cell Lymphoma Treated with Autologous Stem Cell Transplantation
    Amin M. Alousi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Third-Party BK Virus Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation
    Amin M. Alousi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • International Cord Blood Symposium 2013 
    Cord Blood Forum, San Francisco, California - 6/6/2013

Press Mentions

  • 5 Things I Learned from My Non-Hodgkin’s Lymphoma Treatment
    5 Things I Learned from My Non-Hodgkin’s Lymphoma TreatmentMay 14th, 2019
  • ASBMT: A Model for Medical Self-Governance
    ASBMT: A Model for Medical Self-GovernanceFebruary 26th, 2018

Professional Memberships

Hospital Affiliations